Details
- scope
- Long-term PD STN-DBS cohort (n=51, 15+ years follow-up)
- claim_text
- Beyond 15 years after bilateral STN-DBS, time spent with dyskinesia is reduced by 75% and time in OFF by 58.7%, with a 50.6% reduction in dopaminergic medication.
- section_id
- section_14
- source_url
- https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
- effect_size
- Dyskinesia time -75%; OFF time -58.7%; dopaminergic drugs -50.6%
- review_repo
- ComputationalReviewLoops
- section_ref
- wiki_page:computationalreviewloops-14
- source_kind
- review_finding
- source_path
- evidence/section_14_evidence_package.json
- source_span
- Compared to baseline, the time spent with dyskinesia and the time spent in the "off" state were reduced by 75% (p < 0.001) and by 58.7% (p < 0.001), respectively. Moreover, dopaminergic drugs were reduced by 50.6% (p < 0.001).
- study_system
- Long-term PD STN-DBS cohort (n=51, 15+ years follow-up)
- section_title
- Loop Dysfunction in Neurological and Psychiatric Disease
- evidence_summary
- Retrospective cohort of 51 PD patients with mean 17.06 ± 2.18 years of STN-DBS follow-up; pre-op, 1-year, and 15+-year comparisons.
- review_bundle_ref
- analysis_bundle:ab-d49e54403ef9
- replication_status
- independently_replicated
- review_package_ref
- analysis_bundle:ab-d49e54403ef9
- source_artifact_ref
- wiki_page:computationalreviewloops-14
- origin_url
- https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
- commit_sha
- 0632aae8abc141909207fe91f6349b9e36489c3b
- created_by
- persona-jerome-lecoq-gbo-neuroscience
- repository_url
- https://github.com/AllenNeuralDynamics/ComputationalReviewLoops
Raw fields (4)
- raw_fields
{ "n": 51, "doi": "10.1212/wnl.0000000000012246", "claim": "Beyond 15 years after bilateral STN-DBS, time spent with dyskinesia is reduced by 75% and time in OFF by 58.7%, with a 50.6% reduction in dopaminergic medication.", "cite_key": "Bove2021", "evidence": "Retrospective cohort of 51 PD patients with mean 17.06 ± 2.18 years of STN-DBS follow-up; pre-op, 1-year, and 15+-year comparisons.", "effect_size": "Dyskinesia time -75%; OFF time -58.7%; dopaminergic drugs -50.6%", "text_access": "abstract_only", "study_system": "Long-term PD STN-DBS cohort (n=51, 15+ years follow-up)", "source_cluster_id": "cluster_13", "replication_status": "independently_replicated", "claim_source_sentence": "Compared to baseline, the time spent with dyskinesia and the time spent in the \"off\" state were reduced by 75% (p < 0.001) and by 58.7% (p < 0.001), respectively. Moreover, dopaminergic drugs were reduced by 50.6% (p < 0.001).", "replication_evidence_dois": [ "10.21203/rs.3.rs-8860454/v1", "10.21203/rs.3.rs-9205154/v1" ], "effect_size_source_sentence": "Compared to baseline, the time spent with dyskinesia and the time spent in the \"off\" state were reduced by 75% (p < 0.001) and by 58.7% (p < 0.001), respectively. Moreover, dopaminergic drugs were reduced by 50.6% (p < 0.001)." }- source_refs
[ "paper:paper-ed387411989d" ]
- evidence_refs
[ { "ref": "paper:paper-ed387411989d" } ]- source_policy
{ "mode": "public_source_pointer_with_short_context", "notes": [ "Local review repositories are read-only inputs.", "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose." ], "source_commit_sha": "0632aae8abc141909207fe91f6349b9e36489c3b", "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewLoops" }